Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - Monin L; Laing AG; Muñoz-Ruiz M; McKenzie DR; del Molino del Barrio I; Alaguthurai T; Domingo-Vila C; Hayday TS; Graham C; Seow J; Abdul-Jawad S; Kamdar S; et al. (Lancet Oncology, 2021)